RV
RVMDW
Revolution Medicines, Inc.
$1.88
0.00%
$1.3B
No data for this timeframe.
Vol
Market Cap$1.3B
Cap SizeSmall Cap
Inst. Holders12 funds
Inst. Value$11.2M
Inst. Activity0 buys / 2 sells
Reddit Sentiment50° Neutral
SEC Reports8
Exchange Nasdaq·Sector Biological Products, (No Diagnostic Substances)·Inc. DE·CIK 0001628171·Prev Close $1.88
Recent Activity
Apr 17, 2026
SEC
Revolution Medicines has issued $500 million in 0.50% convertible senior notes due 2033, following a series of capital r
8-K — Impact 8/10
Apr 16, 2026
SEC
Revolution Medicines raised approximately $1.65 billion through a public offering of 12.15 million common shares at $142
8-K — Impact 6/10
Apr 15, 2026
SEC
Revolution Medicines is raising $1.44 billion through a public offering of 10.56 million common shares at $142.00 per sh
424B5 — Impact 6/10
Inst.
DRIEHAUS CAPITAL MANAGEMENT LLC — NEAR_EXIT
20,000 shares ($34.8K)
Inst.
TORONTO DOMINION BANK — NEAR_EXIT
10,000 shares ($17.9K)
Latest Reports
BEARISH
8-K
8/10
Revolution Medicines has issued $500 million in 0.50% convertible senior notes due 2033, following a series of capital r
Apr 17, 2026
NEUTRAL
8-K
6/10
Revolution Medicines raised approximately $1.65 billion through a public offering of 12.15 million common shares at $142
Apr 16, 2026
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| ROYAL BANK OF CANADA | — | — |
| LMR Partners LLP | $6.9M | — |
| D. E. Shaw & | $2.7M | — |
| ADAGE CAPITAL PARTNERS GP, | $895.0K | — |
| WOLVERINE ASSET MANAGEMENT LLC | $305.5K | DOUBLED |
Reddit Sentiment
50°
Neutral
Bearish
Neutral
Bullish
12 institutional holders with $11.2M total value (6,862,202 shares) as of 2026-Q1. Top holders: ROYAL, LMR, D.. Net selling activity: 2 institutions trimmed/exited vs 0 added.
Top Institutional Holders — 2026-Q1
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | ROYAL BANK OF CANADA | 200 | $0.00 | 0.0% | — |
| 2 | LMR Partners LLP | 3,838,024 | $6.9M | 61.6% | — |
| 3 | D. E. Shaw & Co., Inc. | 1,580,345 | $2.7M | 24.6% | — |
| 4 | ADAGE CAPITAL PARTNERS GP, L.L.C. | 500,000 | $895.0K | 8.0% | — |
| 5 | WOLVERINE ASSET MANAGEMENT LLC | 170,698 | $305.5K | 2.7% | DOUBLED +120.1% |
| 6 | FARALLON CAPITAL MANAGEMENT LLC | 120,085 | $208.9K | 1.9% | — |
| 7 | TD ASSET MANAGEMENT INC | 40,636 | $70.7K | 0.6% | — |
| 8 | DRIEHAUS CAPITAL MANAGEMENT LLC | 20,000 | $34.8K | 0.3% | NEAR_EXIT -85.2% |
| 9 | TORONTO DOMINION BANK | 10,000 | $17.9K | 0.2% | NEAR_EXIT -91.8% |
| 10 | MORGAN STANLEY | 2,216 | $4.0K | 0.0% | — |
| 11 | PRICE T ROWE ASSOCIATES INC /MD/ | 579,550 | $1.0K | 0.0% | — |
| 12 | TD Waterhouse Canada Inc. | 448 | $790.00 | 0.0% | — |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| DRIEHAUS CAPITAL MANAGEMENT LLC | NEAR_EXIT | 135,000 | 20,000 | -85.2% | $34.8K | 2026-Q1 |
| TORONTO DOMINION BANK | NEAR_EXIT | 121,862 | 10,000 | -91.8% | $17.9K | 2026-Q1 |
| WOLVERINE ASSET MANAGEMENT LLC | DOUBLED | 70,349 | 154,869 | +120.1% | $145.6K | 2025-Q4 |
| TORONTO DOMINION BANK | TRIM | 221,363 | 121,862 | -44.9% | $114.5K | 2025-Q4 |
| Walleye Capital LLC | TRIM | 349,748 | 175,765 | -49.7% | $6.7K | 2025-Q1 |
| UBS Group AG | DOUBLED | 28 | 2,692 | +9514.3% | $485.00 | 2024-Q4 |
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
8 SEC filing reports analyzed. Sentiment: 1 bullish, 5 bearish, 0 mixed, 2 neutral. Avg impact: 6.9/10.
BEARISH
8-K
8/10
Revolution Medicines has issued $500 million in 0.50% convertible senior notes due 2033, following a
Apr 17, 2026
NEUTRAL
8-K
6/10
Revolution Medicines raised approximately $1.65 billion through a public offering of 12.15 million c
Apr 16, 2026
NEUTRAL
424B5
6/10
Revolution Medicines is raising $1.44 billion through a public offering of 10.56 million common shar
Apr 15, 2026
BEARISH
424B5
7/10
Revolution Medicines is raising $500 million through a 0.50% convertible senior notes offering due 2
Apr 15, 2026
BEARISH
144
6/10
Mark A. Goldsmith, a director and officer of Revolution Medicines, intends to sell up to 120,000 sha
Apr 15, 2026
BEARISH
424B5
7/10
Revolution Medicines is conducting a $750 million common stock offering and a concurrent $250 millio
Apr 13, 2026
BEARISH
424B5
7/10
Revolution Medicines is raising $250 million through a convertible senior notes offering, with a con
Apr 13, 2026
BULLISH
8-K
8/10
Revolution Medicines announced positive topline results from its Phase 3 RASolute 302 trial, showing
Apr 13, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-06-30 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.0B | 0.0% | — |
| Next Q 2026-09-30 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.0B | 0.0% | — |
| Current FY 2026-12-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.1B | 0.0% | — |
| Next FY 2027-12-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.8B | 706.4% | — |
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
50°
Neutral
Bearish
Neutral
Bullish
2 mentions
0 bullish
0 bearish
2 time periods
Reddit Sentiment History
| Date | Mentions | Sentiment | Bullish | Bearish | Threads |
|---|---|---|---|---|---|
| Apr 24, 2026 | 1 | 50° Neutral | 0 | 0 | 1 |
| Apr 24, 2026 | 1 | 50° Neutral | 0 | 0 | 1 |
Recent Reddit Threads
RVMD/RVMDW Question
▲ 1
💬 0
⚡ 0.5
No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.